Integene International Overview
Founded
2010
Status
Private
Latest Deal Type
Accelerator/Inc
Latest Deal Amount
$300K
Investors
2
Integene International General Information
Description
Developer of a platform technology intended to treat vascular diseases. The company's technology is developed for the treatment of cardiovascular ischemic disease using combinations of gene and stem cell procedures, enabling patients suffering from vascular diseases gets the required treatment.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 1951 North West 7th Avenue
- Suite 300
- Miami, FL 33136
- United States
Integene International Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 13-Aug-2014 | $300K | 00000 | Completed | Generating Revenue | |
| 2. Angel (individual) | Completed | Startup | ||||
| 1. Grant | $10M | Completed | Startup |
Integene International Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Keith Webster Ph.D | Founder, President & Chief Executive Officer | ||
| Michael Gold | Executive Chairman |
1 Former Executive
Integene International Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Eduardo De Marchenna MD | Integene International | Board Member | 000 0000 |
| Michael Gold | Integene International | Executive Chairman | 000 0000 |
1 Former Board Member
Integene International Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Florida Institute for the Commercialization of Public Research | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | |
| National Institutes of Health | Government | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial